Ironwood Pharmaceuticals | IRWD - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Almirall EUR 713.98M 69K 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amarin USD 649.88M 21.55M 2025-12
Ardelyx USD 382.32M 14.33M 2025-12
Astellas Pharma JPY 1.44T 72.43B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Coherus Biosciences USD 206.71M 254.25M 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Exact Sciences USD 1.56B 34.88M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Lexicon Pharmaceuticals USD 101.9M 20.63M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Moderna USD 6.54B 54M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
Pacira USD 547.97M 14.78M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12